Evidence map›Paper›PMID 30072380›Full record

ArticleThe Journal of biological chemistry2018

MutS homolog sliding clamps shield the DNA from binding proteins.

Jeungphill Hanne, Brooke M Britton, Jonghyun Park, Jiaquan Liu, Juana Martín-López, Nathan Jones, Matthew Schoffner, Piotr Klajner, Ralf Bundschuh, Jong-Bong Lee and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. MutS sliding clamps on an uncertain track to DNA mismatch repair.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jeungphill HanneFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Brooke M BrittonFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Jonghyun ParkDepartment of Physics, Pohang University of Science and Technology (POSTECH), Pohang 790-784 Korea.
Jiaquan LiuFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Juana Martín-LópezFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Nathan JonesFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Matthew SchoffnerFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Piotr KlajnerFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
Ralf BundschuhInterdisciplinary Biophysics Graduate Program, The Ohio State University, Columbus, Ohio 43210, bundschuh@mps.ohio-state.edu.ORCID 0000-0002-6699-8614
Jong-Bong LeeDepartment of Physics, Pohang University of Science and Technology (POSTECH), Pohang 790-784 Korea, jblee@postech.ac.kr.
Richard FishelFrom the Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, rfishel@osu.edu.
The Ohio State University Wexner Medical Center · USPohang University of Science and Technology · KRThe Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The Human Mismatch Repair Proteins and CarcinogenesisR01CA067007 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI Richard Fishel · 1995 to 2026
$9.6M
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA067007
6 · The paper itself

Abstract

Sliding clamps on DNA consist of evolutionarily conserved enzymes that coordinate DNA replication, repair, and the cellular DNA damage response. MutS homolog (MSH) proteins initiate mismatch repair (MMR) by recognizing mispaired nucleotides and in the presence of ATP form stable sliding clamps that randomly diffuse along the DNA. The MSH sliding clamps subsequently load MutL homolog (MLH/PMS) proteins that form a second extremely stable sliding clamp, which together coordinate downstream MMR components with the excision-initiation site that may be hundreds to thousands of nucleotides distant from the mismatch. Specific or nonspecific binding of other proteins to the DNA between the mismatch and the distant excision-initiation site could conceivably obstruct the free diffusion of these MMR sliding clamps, inhibiting their ability to initiate repair. Here, we employed bulk biochemical analysis, single-molecule fluorescence imaging, and mathematical modeling to determine how sliding clamps might overcome such hindrances along the DNA. Using both bacterial and human MSH proteins, we found that increasing the number of MSH sliding clamps on a DNA decreased the association of the

Indexed as

Adenosine TriphosphateBase Pair MismatchDNA, BacterialModels, TheoreticalMutS DNA Mismatch-Binding ProteinProtein BindingSurface Plasmon ResonanceThermusAdenosine TriphosphateDNA, BacterialMutS DNA Mismatch-Binding ProteinDNA binding proteinDNA mismatch repairDNA repairenzyme mechanismfluorescence resonance energy transfer (FRET)MSH2MSH6MutLsingle-molecule biophysicssliding clampsurface plasmon resonance (SPR)

Identifiers

PMID30072380
PMCPMC6139549
OpenAlexW2887176155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.